Table 1 Population features
|  | Overall n = 30 | No CVD n = 16 | CVD n = 14 | p value between CVD status |
|---|---|---|---|---|
Gender, males/females | 14/16 | 6/10 | 8/6 | 0.210 |
Age, years | 64 [59–71] | 62 [59–68] | 68 [64–73] | 0.257 |
Disease duration, years | 56 [51–62] | 55 [51–60] | 56 [52–64] | 0.333 |
BMI, kg/m2 | 26.1 [22.9–28.9] | 26.3 [22.4–28.1] | 26.1 [23.9–30.1] | 0.863 |
Waist to hip ratio | 0.9 [0.8–0.9] | 0.9 [0.8–0.9] | 0.9 [0.8–0.9] | 1.000 |
Insulin dose, IU/kg | 0.45 [0.38–0.58] | 0.46 [0.41–0.58] | 0.44 [0.36–0.54] | 0.830 |
eGFR, ml/min/1.73 m2 | 86.8 [60.0–95.6] | 92.0 [72.0–96.4] | 69.5 [53.0–90.4] | 0.093 |
HbA1c, % | 6.9 [6.6–7.3] | 6.9 [6.3–7.4] | 6.9 [6.6–7.2] | 0.922 |
Total cholesterol, mg/dl | 152 [140–167] | 160 [140–176] | 146 [123–157] | 0.275 |
Triglycerides, mg/dl | 63 [46–80] | 60 [45–75] | 65 [50–86] | 0.236 |
HDL-c, mg/dl | 64 [52–76] | 65 [55–85] | 61 [45–71] | 0.091 |
LDL-c, mg/dl | 68 [61–86] | 69 [63–90] | 67 [60–85] | 0.901 |
Triglycerides/HDL ratio | 1.00 [0.64–1.34] | 0.80 [0.56–1.33] | 1.15 [0.72–1.43] | 0.155 |
Corrected calcium, mg/dl | 9.0 [8.8–9.2] | 9.0 [8.8–9.3] | 9.0 [8.8–9.1] | 0.956 |
25-OH vitamin D, ng/ml | 40 [31–44] | 40 [29–46] | 40 [32–44] | 0.906 |
Alkaline phosphatase, U/l | 62 [46–81] | 59 [52–83] | 66 [45–78] | 0.921 |
hsCRP, mg/dl | 0.14 [0.10–0.26] | 0.13 [0.10–0.37] | 0.15 [0.10–0.24] | 0.630 |